IFPAC 2021

International Forum on Process Analytical Chemistry Annual Meeting 2021 Virtual Meeting – February 28th to March 5th Login to gain access to more content! Non-invasive 3D X-Ray microscopy imaging technique for quantitative characterization of lyophilized drug product With FDA A stable and robust freeze-drying process is highly desirable in pharmaceutical lyophilization to ensure homogenous and […]

AIChE Annual Meeting 2020

American Institution of Chemical Engineers (AIChE) Annual Meeting Virtual Meeting – November 2020 Login to gain access to more content such as videos and download links! Sponsored Talk Workshop: Microstructure Characterization for Drug Development: Novel AI Analytics and Release Prediction  The DigiM team showcases a suite of high resolution image-based tools for quantifying and correlating […]

Next post:

AAPS PharmSci 360 2020

American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 Virtual Meeting – October 2020 Login to gain access to more content such as videos and download links! Rapid Fire Talk: Artificial-Intelligence Image Analysis of API and Microporosity in Drug Products We present the application of our novel image analysis technology to three case studies: controlled release […]

Previous post:

CRS 2020

DigiM Virtual Exhibition Advancing Controlled Release Development with Microstructure Characterization Login to gain access to more content such as videos and download links! Drug Release Modeling Published in AAPS PharmSciTechIn collaboration with Bausch Health For polymer-based controlled release drug products, active pharmaceutical ingredient distribution and microporosity inside the polymer matrix are critical for product performance. […]

DigiM Featured in FDA Workshop

DIGIM FEATURED IN FDA WORKSHOP DigiM’s Quantitative Image Characterization Featured in FDA Workshop Burlington, MA – June 9, 2020 DigiM Solution LLC, a software and technology solution company, was invited to present at the Food and Drug Administration (FDA) public workshop “Generic Drug Regulatory Science Initiatives,” held virtually on May 4, 2020. Dr. Shawn Zhang, the company’s […]

Next post:

DigiM Receives FDA Contract to Study Microstructure Bioequivalence

DigiM Receives FDA Contract to Study Microstructure Bioequivalence DigiM Solution LLC awarded FDA contract for a micro-imaging and image-based modeling study to establish Q3 microstructure bioequivalence of polymer-based long-acting drugs, in collaboration with the Diane Burgess Laboratory at UConn. Burlington Mass., Dec. 9th, 2019 – DigiM Solution LLC, a provider of microstructure characterization and optimization […]